2,163
Views
16
CrossRef citations to date
0
Altmetric
Mini-Review

Sex, Eyes, and Vision: Male/Female Distinctions in Ophthalmic Disorders

Pages 96-101 | Received 20 Aug 2014, Accepted 07 Oct 2014, Published online: 20 Oct 2014

REFERENCES

  • Rosner W, Hankinson SE, Sluss PM, Vesper HW, Wierman ME. Challenges to the measurement of estradiol: an Endocrine Society position statement. J Clin Endocrinol Metab 2013;98:1376–1387
  • Clarke BL, Khosla S. Female reproductive system and bone. Arch Biochem Biophys 2010;503:118–128
  • Winters-Stone KM, Torgrimson B, Horak F, Eisner A, Nail L, Leo MC, et al. Identifying factors associated with falls in postmenopausal breast cancer survivors: a multi-disciplinary approach. Arch Phys Med Rehabil 2011;92:646–652
  • The ESHRE Capri Workshop Group. Bone fractures after menopause. Hum Reprod Update 2010;16:761–773
  • Laurent M, Antonio L, Sinnesael M, Dubois V, Gielen E, Classens F, et al. Androgens and estrogens in skeletal sexual dimorphism. Asian J Androl 2014;16:213–222
  • Santen RJ, Brodie H, Simpson ER, Siiteri PK, Brodie A. History of aromatase: saga of an important biological mediator and therapeutic target. Endocr Rev 2009;30:343–375
  • Luu-The V. Assessment of steroidogenesis and steroidogenic enzyme functions. Steroid Biochem Mol Biol 2013;137:176–182
  • Li J, Daly E, Campioli E, Wabitsch M, Papadopoulos V. De novo synthesis of steroids and oxysterols in adipocytes. J Biol Chem 2014;289:747–764
  • Pöllänen E, Sipilä S, Alen M, Ronkainen PH, Ankarberg-Lindgren C, Puolakka J, et al. Differential influence of peripheral and systemic sex steroids on skeletal muscle quality in pre-and postmenopausal women. Aging Cell 2011;10:650–660
  • Ferraldeschi R, Sharifi N, Auchus RJ, Attard G. Molecular pathways: inhibiting steroid biosynthesis in prostate cancer. Clin Cancer Res 2013;19:3353–3359
  • Slominski A, Zbytek B, Nikolakis G, Manna PR, Skobowiat C, Zmijewski M, et al. Steroidogenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol 2013;137:107–123
  • Yarrow JF, McCoy SC, Borst SE. Intracrine and myotrophic roles of 5α-reductase and androgens: a review. Med Sci Sports Exerc 2012;44:818–826
  • Melcangi RC, Giatti S, Pesaresi M, Calabrese D, Mitro N, Caruso D, et al. Role of neuroactive steroids in the peripheral nervous system. Front Endocrinol (Lausanne) 2011;2:104. doi: 10.3389/fendo.2011.00104. eCollection 2011
  • Thomas MP, Potter BV. The structural biology of oestrogen metabolism. J Steroid Biochem Mol Biol 2013;137:27–49
  • Gillies GE, McArthur S. Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev 2010;62:155–198
  • Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003;86:225–230
  • Sorwell KG, Kohama SG, Urbanski HF. Perimenopausal regulation of steroidogenesis in the nonhuman primate. Neurobiol Aging 2012;33:1487.e1–1437.e13
  • Krause DN, Duckles SP, Gonzales RJ. Local oestrogenic/androgenic balance in the cerebral vasculature. Acta Physiol (Oxf) 2011;203:181–186
  • Liu M, Kelley MH, Herson PS, Hurn PD. Neuroprotection of sex steroids. Minerva Endocrinol 2010;35:127–143
  • Bringmann A, Grosche A, Pannicke T, Reichenbach A. GABA and glutamate uptake and metabolism in retinal glial (Müller) cells. Front Endocrinol (Laussane) 2013;4:48. doi: 10.3389/fendo.2013.00048. eCollection 2013
  • Morgan JE. Retina ganglion cell degeneration in glaucoma: an opportunity missed? A review. Clin Experiment Ophthalmol 2012;40:364–368
  • McCarthy MM. What can development teach us about menopause? Brain Res 2011;1379:109–118
  • Vitale C, Mendelsohn ME, Rosano GM. Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 2009;6:532–542
  • Riva CE, Falsini B, Logean E. Flicker-evoked responses of human optic nerve head blood flow: luminance versus chromatic modulation. Invest Ophthalmol Vis Sci 2001;42:756–762
  • Zhong Z, Huang G, Chui TY, Petrig BL, Burns SA. Local flicker stimulation evokes local retinal blood velocity changes. J Vis 2012;12(6):3. doi: 10.1167/12.6.3
  • Kiernan DF, Mieler WF, Hariprasad SM. Spectral-domain optical coherence tomography: a comparison of modern high-resolution retinal imaging systems. Am J Ophthalmol 2010;149:18–31
  • Carroll J, Kay DB, Scoles D, Dubra A, Lombardo M. Adaptive optics retinal imaging–clinical opportunities and challenges. Curr Eye Res 2013;38:709–721
  • Gameiro CM, Romao F, Castelo-Branco C. Menopause and aging: changes in the immune system–a review. Maturitas 2010;67:316–320
  • Gomez FP, Steelman AJ, Young CR, Welsh CJ. Hormone and immune system interactions in demyelinating disease. Horm Behav 2013;63:315–321
  • Porola P, Virkki L, Przybyla BD, Laine M, Patterson TA, Pihakari A, et al. Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sjögren's syndrome. J Rheumatol 2008;35:2229–2235
  • Meyer MR, Clegg DJ, Prossnitz ER, Barton M. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxf) 2011;203:259–269
  • Truong S, Cole N, Stapleton F, Golebiowski B. Sex hormones and the dry eye. Clin Exper Optom 2014;97:324–336
  • Kimura K, Orita T, Fujitsu Y, Liu Y, Wakuta M, Morishige N, et al. Inhibition by female sex hormones of collagen gel contraction mediated by retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2014;55:2621–2630
  • Miller VM, Kirchengast S. Why are sex and gender important to basic physiology and translational and individualized medicine? Am J Physiol Heart Circ Physiol 2014;306:H781–H788
  • Clayton JA, Collins FS. Policy: NIH to balance sex in cell and animal studies. Nature 2014;509:282–283
  • Marshak DW, Martin PR. Short wavelength-sensitive cones and the processing of their signals. Vis Neurosci 2014;31:111–113
  • Greendale GA, Derby CA, Maki PM. Perimenopause and cognition. Obstet Gynecol Clin North Am 2011;38:519–535
  • Mott NN, Pak TR. Estrogen signaling and the aging brain: Context-dependent considerations for postmenopausal hormone therapy. ISRN Endocrinol 2013; doi:10.1155/2013/814690
  • Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 2013;310:1353–1368
  • Kreatsoulas C, Anand SS. Menopausal hormone therapy for the primary prevention of chronic conditions. U.S. Preventive Services Task Force recommendation statement. Pol Arch Med Wewn 2013;123:112–117
  • Eisner A, Demirel S. Variability in short-wavelength automated perimetry among peri- or postmenopausal women: a dependence on phyto-oestrogen consumption? Acta Ophthalmol 2011;89:e217–e224
  • North American Menopause Society. The role of soy isoflavones in menopausal health: report of the North American Menopause Society/Wulf H. Utian translational science symposium in Chicago, IL (October 2010). Menopause 2011;18:732–753
  • Kwak HS, Park SY, Kim MG, Yim CH, Yoon HK, Han KO. Marked individual variation in isoflavone metabolism after a soy challenge can modulate the skeletal effect of isoflavones in premenopausal women. J Korean Med Sci 2009;24:867–873
  • Qin W, Zhu W, Shi H, Hewett JE, Ruhlen RL, MacDonald RS, et al. Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women. Nutr Cancer 2009;61:238–244
  • Kurzer MS. Hormonal effects of soy in premenopausal women and men. J Nutr 2002;132:570S–573S
  • Wang AT, Fan J, Van Houten HK, Tilburt JC, Stout NK, Montori VM, et al. Impact of the 2009 US Preventive Services Task Force guidelines on screening mammography rates on women in their 40s. PLoS One 2014;9:e91399. doi: 10.1371/journal.pone.0091399. eCollection 2014
  • Welch HG, Passow HJ. Quantifying the benefits and harms of screening mammography. JAMA Intern Med 2014;174:448–454
  • Voogd AC. The impact of mammography screening on breast cancer incidence. J Comp Eff Res 2013;2:113–116
  • Cowell CF, Weigelt B, Sakr RA, Ng CK, Hicks J, King TA, et al. Progression from ductal carcinoma in situ to invasive breast cancer: revisited. Mol Oncol 2013;7:859–869
  • Burstein HJ, Temin S, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, et al. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update. J Clin Oncol 2014;32:2255–2269
  • Anderson WF, Katki HA, Rosenberg PS. Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst 2011;103:1397–1402
  • Eisner A, Luoh SW. Breast cancer medications and vision: effects of treatments for early-stage disease. Curr Eye Res 2011;36:867–885
  • Markopoulos C. Overview of the use of Oncotype DX® as an additional treatment decision tool in early breast cancer. Expert Rev Anticancer Ther 2013;13:179–194
  • Eiermann W, Rezai M, Kummel S, Kuhn T, Warm M, Friedrichs K, et al. The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use. Ann Oncol 2013;24:618–624

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.